Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Eli Lilly
LLY
|
$492M |
| 2 |
Starbucks
SBUX
|
$303M |
| 3 |
GE Aerospace
GE
|
$251M |
| 4 |
Canadian National Railway
CNI
|
$218M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$209M |
Top Sells
| 1 |
Merck
MRK
|
$391M |
| 2 |
AbbVie
ABBV
|
$248M |
| 3 |
Bristol-Myers Squibb
BMY
|
$220M |
| 4 |
Comcast
CMCSA
|
$161M |
| 5 |
LyondellBasell Industries
LYB
|
$140M |
Sector Composition
| 1 | Healthcare | 14.63% |
| 2 | Financials | 13.7% |
| 3 | Technology | 9.85% |
| 4 | Industrials | 9.84% |
| 5 | Energy | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Verizon
VZ
$186B
| $1.72B | 2.91% | 36,818,448 +3,695,400 | +11% | +$172M |
|
2
Microsoft
MSFT
$3.77T
| $1.61B | 2.73% | 36,494,905 +1,931,538 | +6% | +$85.3M |
|
3
Texas Instruments
TXN
$184B
| $1.29B | 2.18% | 24,982,595 +965,006 | +4% | +$49.7M |
|
4
ConocoPhillips
COP
$124B
| $1.14B | 1.94% | 18,598,975 +1,173,516 | +7% | +$72.1M |
|
5
Wells Fargo
WFC
$263B
| $1.08B | 1.84% | 19,265,300 +1,935,600 | +11% | +$109M |
|
6
Coca-Cola
KO
$297B
| $1.03B | 1.74% | 26,133,433 +1,290,088 | +5% | +$50.6M |
|
7
Philip Morris
PM
$260B
| $894M | 1.52% | 11,149,306 +1,036,300 | +10% | +$83.1M |
|
8
CME Group
CME
$96B
| $852M | 1.44% | 9,151,795 | – | – |
|
9
Lockheed Martin
LMT
$106B
| $840M | 1.42% | 4,518,829 +477,100 | +12% | +$88.7M |
|
10
Chevron
CVX
$324B
| $836M | 1.42% | 8,669,900 -419,050 | -5% | -$40.4M |
|
11
Home Depot
HD
$405B
| $829M | 1.41% | 7,460,937 +115,467 | +2% | +$12.8M |
|
|
12
Bristol-Myers Squibb
BMY
$96B
| $823M | 1.4% | 12,370,291 -3,311,394 | -21% | -$220M |
|
13
Newell Brands
NWL
$2.48B
| $793M | 1.35% | 19,300,493 +993 | +0% | +$40.8K |
|
14
Pfizer
PFE
$141B
| $782M | 1.33% | 23,314,931 +25,700 | +0.1% | +$862K |
|
15
Procter & Gamble
PG
$368B
| $755M | 1.28% | 9,652,161 +1,268,161 | +15% | +$99.2M |
|
16
Goldman Sachs
GS
$226B
| $750M | 1.27% | 3,593,817 +177,517 | +5% | +$37.1M |
|
17
Enbridge
ENB
$105B
| $740M | 1.26% | 15,828,246 +1,449,476 | +10% | +$67.8M |
|
18
Gilead Sciences
GILD
$140B
| $735M | 1.25% | 6,278,500 | – | – |
|
19
DuPont de Nemours
DD
$32.2B
| $714M | 1.21% | 13,956,452 +2,500,000 | +22% | +$128M |
|
|
20
AbbVie
ABBV
$372B
| $702M | 1.19% | 10,451,196 -3,695,700 | -26% | -$248M |
|
|
21
Merck
MRK
$210B
| $654M | 1.11% | 11,479,380 -6,863,495 | -37% | -$391M |
|
|
MON
22
DELISTED
Monsanto Co
MON
| $631M | 1.07% | 5,924,321 +992,821 | +20% | +$106M |
|
23
Boeing
BA
$177B
| $596M | 1.01% | 4,294,400 +847,800 | +25% | +$118M |
|
|
24
Eli Lilly
LLY
$657B
| $587M | 0.99% | 7,029,300 +5,889,300 | +517% | +$492M |
|
25
JPMorgan Chase
JPM
$829B
| $564M | 0.96% | 8,316,800 +1,289,100 | +18% | +$87.3M |
|